A study of centanafadine for adults with ADHD and emotional symptoms
Part of Mental health clinical trials.
This study tests an investigational medicine called centanafadine for adults with ADHD who also have trouble managing their emotions. The goal is to see if the medicine can help improve both attention and emotional control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult with a formal ADHD diagnosis.
- Your ADHD symptoms must be at least moderate, and you must also have significant emotional symptoms.
- You must not have certain other mental health conditions like bipolar disorder, schizophrenia, or borderline personality disorder.
- You must not currently have major depression, PTSD, substance use disorder, or untreated sleep apnea.
- You must not have tried and failed two or more ADHD medications from different classes during adulthood.
- You must not have taken centanafadine before or participated in another drug trial within the past 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the medication Dyanavel XR (a long-acting amphetamine) can help reduce fatigue in adults with ADHD. It is for people who have both ADHD and significant tiredness, and who are not currently taking stimulant ADHD drugs.
This study tests a medication called Foquest to see if it helps older adults with ADHD. It aims to improve attention and reduce hyperactivity or impulsivity in people aged 65 and above.
This study tests if Jornay PM, a long-acting ADHD medication, helps control symptoms, focus, and emotions throughout the day and into the early evening in adults with ADHD. It is an open-label study, meaning everyone knows they are getting the medication, and then they are randomly assigned to different observation groups.
This study tests whether a supplement called N-acetylcysteine (NAC) can help children aged 6-12 who have intense emotions and mood swings. It also looks at brain activity before and after treatment to see if NAC might improve emotional control.
This study tests a long-acting form of the medicine clonidine (called Onyda XR) to see if it safely reduces symptoms of ADHD and oppositional defiant disorder in children. Children who join will take the study medicine or a placebo for a set period, and their symptoms will be tracked.
This trial tests a new medication called EB-1020 for adults with ADHD. It aims to see if the drug is safe and effective in improving ADHD symptoms. You may be able to join if you have a clear ADHD diagnosis and your symptoms are moderate to severe.
Hear when a new ADHD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.